Total Valuation
China SXT Pharmaceuticals has a market cap or net worth of €72.09M. The enterprise value is -€18.25M.
Market Cap€72.09M
Enterprise Value-€18.25M
Share Statistics
China SXT Pharmaceuticals has 32,218,080 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,218,080
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China SXT Pharmaceuticals’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -23.11%.
Return on Equity (ROE)-0.21
Return on Assets (ROA)-0.18
Return on Invested Capital (ROIC)-23.11%
Return on Capital Employed (ROCE)-0.23
Revenue Per Employee19.15K
Profits Per Employee-110.81K
Employee Count56
Asset Turnover0.03
Inventory Turnover0.30
Valuation Ratios
The current PE Ratio of China SXT Pharmaceuticals is ―. China SXT Pharmaceuticals’s PEG ratio is -0.02.
PE Ratio―
PS Ratio1.06
PB Ratio0.04
Price to Fair Value0.04
Price to FCF-0.28
Price to Operating Cash Flow-0.40
PEG Ratio-0.02
Income Statement
In the last 12 months, China SXT Pharmaceuticals had revenue of 1.07M and earned -6.21M in profits. Earnings per share was -9.13.
Revenue1.07M
Gross Profit183.28K
Operating Income-7.12M
Pretax Income-6.07M
Net Income-6.21M
EBITDA-6.98M
Earnings Per Share (EPS)-9.13
Cash Flow
In the last 12 months, operating cash flow was -5.15M and capital expenditures -4.00, giving a free cash flow of -5.15M billion.
Operating Cash Flow-5.15M
Free Cash Flow-5.15M
Free Cash Flow per Share-0.16
Dividends & Yields
China SXT Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.47
52-Week Price Change-99.21%
50-Day Moving Average0.04
200-Day Moving Average2.05
Relative Strength Index (RSI)0.00
Average Volume (3m)0.00
Important Dates
China SXT Pharmaceuticals upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
China SXT Pharmaceuticals as a current ratio of 7.93, with Debt / Equity ratio of 3.77%
Current Ratio7.93
Quick Ratio7.25
Debt to Market Cap0.93
Net Debt to EBITDA3.88
Interest Coverage Ratio-113.13
Taxes
In the past 12 months, China SXT Pharmaceuticals has paid 130.84K in taxes.
Income Tax130.84K
Effective Tax Rate-0.02
Enterprise Valuation
China SXT Pharmaceuticals EV to EBITDA ratio is 3.71, with an EV/FCF ratio of 6.45.
EV to Sales-24.16
EV to EBITDA3.71
EV to Free Cash Flow6.45
EV to Operating Cash Flow6.45
Balance Sheet
China SXT Pharmaceuticals has €28.18M in cash and marketable securities with €1.12M in debt, giving a net cash position of €27.06M billion.
Cash & Marketable Securities€28.18M
Total Debt€1.12M
Net Cash€27.06M
Net Cash Per Share€0.84
Tangible Book Value Per Share€43.70
Margins
Gross margin is 44.37%, with operating margin of -664.06%, and net profit margin of -578.49%.
Gross Margin44.37%
Operating Margin-664.06%
Pretax Margin-566.29%
Net Profit Margin-578.49%
EBITDA Margin-650.71%
EBIT Margin-664.06%
Analyst Forecast
The average price target for China SXT Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―